Scientists hunt for biomarkers to personalize ventilator care in ARDS
NCT ID NCT07380997
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will analyze blood and sputum samples from 411 adults with acute respiratory distress syndrome (ARDS) who are on ventilators. Researchers will look for patterns in microbes, metabolites, and gene activity to see if they can predict how well patients respond to ventilation and their 28-day survival. The goal is to find biomarkers that could one day guide personalized ventilator strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify molecular markers that help doctors personalize ventilator settings for ARDS patients, potentially improving survival.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any direct clinical changes, and the findings might not apply to all ARDS patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues may unlock better ECMO care for lung failure patients
- New study aims to Fine-Tune ventilator strategies for ARDS patients
- Can the right dose and timing of steroids save more lives in ARDS?
- New inflatable cushion could revolutionize ICU patient repositioning
- Tailored breathing support may reduce lung injury in ECMO patients
- ARDS ventilator tool faces reliability test